- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06217679
Comparing the Effects of Different Types of Exercise on Glucose Handling
February 2, 2024 updated by: University of Waterloo
Comparing the Effects of Different Types of Exercise on Glucose Handling and Muscle Metabolism in Young Males and Females
The purpose of the proposed study is to compare the acute effects of different types of exercise modalities on glucose handling in young, healthy males and females.
The exercise modalities that will be compared include: a high intensity interval exercise (HIIE) protocol, a moderate intensity continuous exercise (MICE) protocol and a low-load, high-repetition (LL-HR) resistance exercise protocol.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to compare the effects of different exercise modalities (High intensity interval exercise, Moderate intensity continuous exercise, and Low-load-high repetition resistance exercise) on blood sugar control in young healthy, males and females.
To test this theory, a sugar challenge (oral glucose tolerance test - OGTT) will be performed during the pre-testing visit to determine the baseline blood sugar response.
An OGTT will also be performed 2 hours after each single exercise session to determine how each type of exercise affects the blood sugar response.
Investigators will take multiple blood samples throughout the trial to allow us to measure blood sugar, insulin and concentrations and oxidative stress.
Muscle biopsies will be taken before and after each exercise bout so that investigators can examine the underlying mechanisms that contribute to the effectiveness of the different types of exercise on blood sugar control.
Investigators will also use an ultrasound to measure factors related to of cardiovascular health such as artery stress and vascular conductance during the exercise bouts.
Direct benefits of this study include characterizing sex differences of blood sugar handling after single exercise sessions.
This study could have direct benefits on deterring the effectiveness of different forms of exercise on blood sugar levels.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- University of Waterloo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- In order to participate in this study, participants must be a healthy man or woman between the ages of 18 and 30 years.
Exclusion Criteria:
Presence of chronic health condition(s) [i.e. metabolic (i.e. Type 1 or type 2 diabetes), cardiovascular (i.e hypertension), respiratory (i.e. chronic pulmonary obstructive disorder) or digestive (i.e. ulcerative colitis) disorders.
- Are pregnant, or suspect that they may be pregnant, or nursing
- Inability to complete the single exercise sessions.
- Regularly participate in cardiovascular (>3 sessions/week) or resistance training (>2 sessions/week) exercise.
- Have an allergy to local anesthetic (or family history of allergy)
- Have undergone a barium swallow or an infusion of a contrast agent in the past 3 weeks
- Are taking prescription anti-coagulant or anti-platelet medications (e.g., warfarin, heparin, clopidogrel)
- Inability to exercise as suggested by the get active questionnaire (GAQ)
- BMI > 27 kg/m2
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Control Oral Glucose Tolerance Test
This visit will include a baseline OGTT to be used as a pre-exercise baseline measure for each of the arms.
Participants will then consume a 75g glucose beverage (Trutol, Thermo Scientific) and blood samples will be drawn at 0, 10, 20, 30, 45, 60, 75, 90 and 120 minutes post consumption.
|
control oral glucose tolerance test
exercise performed in randomized order
|
Experimental: High intensity interval exercise (HIIE)
Participants performed a High intensity interval exercise (HIIE) bout which includes 10 x 1 min at 90% maximum heart rate (HRmax) with 5 min warm up and 5 min cool down at 50watts (low state steady cycling).
90mins following the exercise bout participants will undergo another oral glucose tolerance test.
|
control oral glucose tolerance test
exercise performed in randomized order
|
Experimental: Moderate intensity continuous exercise (MICE)
Participants performed a Moderate intensity continuous exercise (MICE) bout which includes 30 min at 65% maximal aerobic capacity (VO2max).
90mins following the exercise bout participants will undergo another oral glucose tolerance test.
|
control oral glucose tolerance test
exercise performed in randomized order
|
Experimental: Low-load, high-repetition resistance exercise (LL-HR)
Participants performed a Low-load, high-rep resistance exercise (LL-HR) bout which includes a whole body resistance exercise bout, 3 sets at 30% maximum strength (1RM) for leg press, knee extension, hamstring curl, lat pulldown, shoulder press, chest press, 20-25 reps, last set to failure.
90mins following the exercise bout participants will undergo another oral glucose tolerance test.
|
control oral glucose tolerance test
exercise performed in randomized order
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insulin sensitivity change
Time Frame: 120mins
|
Assess the changes in insulin sensitivity pre to post exercise
|
120mins
|
Blood insulin change
Time Frame: 120mins
|
To assess the effect of sex and exercise on basal and post-exercise blood insulin
|
120mins
|
Blood glucose change
Time Frame: 120mins
|
To assess the effect of sex and exercise on basal and post-exercise blood glucose.
|
120mins
|
Blood c-peptide change
Time Frame: 120mins
|
To assess the effect of sex and exercise on basal and post-exercise blood c-peptide.
|
120mins
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
TBC1 domain family member 4 change (TBC1D4)
Time Frame: 35mins
|
examine protein content changes from pre to post exercise
|
35mins
|
TBC1 domain family member 1 change (TBC1D1)
Time Frame: 35mins
|
examine protein content changes from pre to post exercise
|
35mins
|
protein kinase B change
Time Frame: 35mins
|
examine protein content changes from pre to post exercise
|
35mins
|
5' adenosine monophosphate-activated protein kinase change
Time Frame: 35mins
|
examine protein content changes from pre to post exercise
|
35mins
|
glucose transporter 4 change (GLUT4)
Time Frame: 35mins
|
examine protein content changes from pre to post exercise
|
35mins
|
estrogen concentration
Time Frame: 30mins
|
to assess the differences in estrogen concentration between males and females
|
30mins
|
progesterone concentration
Time Frame: 30mins
|
to assess the differences in progesterone concentration between males and females
|
30mins
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2018
Primary Completion (Actual)
October 31, 2019
Study Completion (Actual)
October 31, 2019
Study Registration Dates
First Submitted
January 8, 2024
First Submitted That Met QC Criteria
January 19, 2024
First Posted (Actual)
January 22, 2024
Study Record Updates
Last Update Posted (Estimated)
February 6, 2024
Last Update Submitted That Met QC Criteria
February 2, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ORE #22477
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Sensitivity
-
Paloma Almeda-ValdésCompleted
-
Ingredion IncorporatedUnknownFocus of the Study is Insulin SensitivityUnited States
-
University of Colorado, DenverRecruitingEndothelial Dysfunction | Vascular Stiffness | Insulin Sensitivity/Resistance | TransgenderismUnited States
-
University of Texas, El PasoCompletedInsulin Sensitivity/ResistanceUnited States
-
Rigshospitalet, DenmarkUnknownInsulin Sensitivity and Lipid Metabolism
-
Maastricht University Medical CenterCompletedVascular Function | Nitrate | Brain Insulin-sensitivityNetherlands
-
University of Alabama at BirminghamNot yet recruitingCardiovascular Diseases | Obesity | Insulin Sensitivity/Resistance | Metabolic Disease | Energy Expenditure | MetabolismUnited States
-
University Hospital TuebingenCompletedInsulin SensitivityGermany
-
University of CopenhagenCompleted
-
Marjukka KolehmainenKuopio University HospitalCompleted
Clinical Trials on Control Oral Glucose Tolerance Test
-
University Hospital Schleswig-HolsteinUniversity of KielRecruitingParkinson Disease | Nutritional and Metabolic Diseases | Sugar IntakeGermany
-
University College DublinCompletedHealthy SubjectsIreland
-
NYU Langone HealthCompletedGlucose Metabolism Disorders | Diabetes Mellitus | Prediabetic State | Diabetes, GestationalUnited States
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Children's Hospital of PhiladelphiaCystic Fibrosis FoundationRecruitingCystic Fibrosis | Cystic Fibrosis-related DiabetesUnited States
-
Ankara City Hospital BilkentRecruitingGestational Diabetes | Glucose Intolerance During PregnancyTurkey
-
Christophe De BlockUnknownDiabetes Mellitus | Stress HyperglycemiaBelgium
-
Zhujiang HospitalRecruitingDiabetes Mellitus | Prediabetes | Gestational Diabetes Mellitus | ProteomicsChina
-
University of NottinghamCompletedGastrointestinal DysfunctionUnited Kingdom
-
Seoul National University HospitalCompletedDiabete Mellitus | Pancreatectomy; Hyperglycemia